State of Tennessee, Department of Treasury’s ANI Pharmaceuticals ANIP Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$563K	Buy	7,327 +3,300	+82%	+$258K	﹤0.01%	1400
2025 Q4	$330K	Sell	4,027 -1,735	-30%	-$150K	﹤0.01%	1529
2025 Q3	$528K	Hold	5,762	–	–	﹤0.01%	1408
2025 Q2	$376K	Buy	5,762 +2,032	+54%	+$132K	﹤0.01%	1471
2025 Q1	$250K	Hold	3,730	–	–	﹤0.01%	1566
2024 Q4	$206K	Sell	3,730 -4,414	-54%	-$253K	﹤0.01%	1621
2024 Q3	$486K	Sell	8,144 -2,191	-21%	-$134K	﹤0.01%	1437
2024 Q2	$658K	Buy	10,335 +814	+9%	+$52.8K	﹤0.01%	1323
2024 Q1	$658K	Sell	9,521 -505	-5%	-$30.5K	﹤0.01%	1302
2023 Q4	$553K	Buy	10,026 +2,585	+35%	+$142K	﹤0.01%	1371
2023 Q3	$432K	Hold	7,441	–	–	﹤0.01%	1339
2023 Q2	$401K	Buy	7,441 +3,289	+79%	+$146K	﹤0.01%	1457
2023 Q1	$165K	Sell	4,152 -912	-18%	-$38.5K	﹤0.01%	1567
2022 Q4	$204K	Hold	5,064	–	–	﹤0.01%	1526
2022 Q3	$163K	Buy	5,064 +232	+5%	+$7.94K	﹤0.01%	1553
2022 Q2	$143K	Buy	4,832 +1,175	+32%	+$33.9K	﹤0.01%	1581
2022 Q1	$103K	Buy	3,657 +554	+18%	+$20.7K	﹤0.01%	1652
2021 Q4	$143K	Hold	3,103	–	–	﹤0.01%	1625
2021 Q3	$102K	Sell	3,103 -331	-10%	-$10.3K	﹤0.01%	1639
2021 Q2	$120K	Sell	3,434 -4,276	-55%	-$145K	﹤0.01%	1612
2021 Q1	$279K	Buy	7,710 +2	+0%	+$63	﹤0.01%	1477
2020 Q4	$224K	Buy	7,708 +304	+4%	+$8.71K	﹤0.01%	1457
2020 Q3	$209K	Buy	7,404 +802	+12%	+$23.9K	﹤0.01%	1387
2020 Q2	$213K	Buy	6,602 +345	+6%	+$12.4K	﹤0.01%	1397
2020 Q1	$255K	Buy	6,257 +3,114	+99%	+$166K	﹤0.01%	1309
2019 Q4	$194K	Sell	3,143 -484	-13%	-$32.1K	﹤0.01%	1468
2019 Q3	$264K	Sell	3,627 -3,579	-50%	-$268K	﹤0.01%	1428
2019 Q2	$593K	Sell	7,206 -499	-6%	-$35.5K	﹤0.01%	1163
2019 Q1	$544K	Buy	7,705 +757	+11%	+$44.5K	﹤0.01%	1210
2018 Q4	$313K	Sell	6,948 -615	-8%	-$32.2K	﹤0.01%	1325
2018 Q3	$428K	Buy	7,563 +1,375	+22%	+$84.1K	﹤0.01%	1336
2018 Q2	$413K	Sell	6,188 -216	-3%	-$13.5K	﹤0.01%	1364
2018 Q1	$373K	Sell	6,404 -673	-10%	-$42.7K	﹤0.01%	1365
2017 Q4	$456K	Sell	7,077 -16	-0.2%	-$995	﹤0.01%	1366
2017 Q3	$372K	Sell	7,093 -448	-6%	-$21.4K	﹤0.01%	1380
2017 Q2	$353K	Hold	7,541	–	–	﹤0.01%	1422
2017 Q1	$373K	Buy	7,541 +1,499	+25%	+$84.2K	﹤0.01%	1418
2016 Q4	$366K	Hold	6,042	–	–	﹤0.01%	1424
2016 Q3	$401K	Hold	6,042	–	–	﹤0.01%	1312
2016 Q2	$337K	Hold	6,042	–	–	﹤0.01%	1315
2016 Q1	$203K	Buy	6,042 +142	+2%	+$4.82K	﹤0.01%	1366
2015 Q4	$266K	Buy	+5,900	New	+$254K	﹤0.01%	1334
2015 Q3	–	Sell	-6,400	Closed	-$397K	–	889
2015 Q2	$397K	Hold	6,400	–	–	﹤0.01%	1295
2015 Q1	$400K	Buy	+6,400	New	+$389K	﹤0.01%	1328

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State of Tennessee, Department of Treasury's ANIP Position: Q1 2026 in Review

State of Tennessee, Department of Treasury increased its ANI Pharmaceuticals (ANIP) stake by 82% in Q1 2026, buying an estimated $258K and bringing the position to 7,327 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

State of Tennessee, Department of Treasury first reported a position in ANIP in Q1 2015 and has held it in 44 quarters since. The position peaked at $658K in Q1 2024. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

State of Tennessee, Department of Treasury held 7,327 shares of ANI Pharmaceuticals worth $563K as of Q1 2026.
State of Tennessee, Department of Treasury bought 3,300 ANI Pharmaceuticals shares in Q1 2026, an estimated $258K.
ANI Pharmaceuticals made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1400 holding.
State of Tennessee, Department of Treasury first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 44 quarters since.
State of Tennessee, Department of Treasury's ANI Pharmaceuticals position peaked at $658K in Q1 2024.
280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.